"UBMD Pediatrics is one of 18 practice plans within UBMD Physicians’ Group, the single largest medical group in Western New York. We provide premier health care to infants, children, adolescents, and young adults throughout Western New York and beyond. In addition to primary care pediatrics, we are the only pediatric group in the area with 14 pediatric subspecialties. Our doctors make up the academic teaching faculty within the Department of Pediatrics at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo and are also the physicians at Oishei Children’s Hospital."

During the past decade, UBMD Pediatrics conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UBMD Pediatrics" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "State University of New York at Buffalo" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Lumos Pharma" with 1 trials sponsored and "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UBMD Pediatrics" #1 collaborator was "Hadley Jo Foundation" with 1 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 1 trials as a collaborator and "The Callum McKeefery and Nikki Albano McKeefery Pediatric Division of Genetics Fund" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "UBMD Pediatrics" are "Mitochondrial Diseases" (2 trials), "Neurodegenerative Disease, Hereditary" (2 trials), "Optic Atrophy" (2 trials), "Diabetes Mellitus, Type 2" (1 trials) and "Growth Hormone Deficiency" (1 trials). Many other conditions were trialed in "UBMD Pediatrics" in a lesser frequency.

Most popular intervention types in "UBMD Pediatrics" are "Drug" (5 trials) and "Genetic" (2 trials). Other intervention types were less common.

The name of intervention was led by "Mutation analysis" (2 trials), "Placebo" (2 trials), "Empagliflozin" (1 trials), "Glucagon Nasal Powder [Baqsimi]" (1 trials) and "Hydroxychloroquine" (1 trials). Other intervention names were less common.

The vast majority of trials in "UBMD Pediatrics" are 7 trials for "All" genders.

Currently, there are NaN active trials in "UBMD Pediatrics". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in UBMD Pediatrics, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in UBMD Pediatrics, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".